iRhythm Technologies Snags $10M

San Francisco-based iRhythm Technologies, which develops a cardiac rhythm monitor, has scored $10M in a funding from St. Jude Medical, Mohr Davidow Ventures, and Synergy Life Science Partners, St. Jude and iRhythm announced Thursday. According to the firms, the investment comes as part of a partnership, where the two will co-market iRhythm's cardiac rhythm monitor. iRhythm's devices are single-use devices used in heart arrythmia patients, used to collect diagnostic information in patients. More information »